Citation Impact
Citing Papers
Oxidative Stress
2017 Standout
Ferroptosis regulation by the NGLY1/NFE2L1 pathway
2022 StandoutNobel
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection
2014
Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease
2014
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data
2007 Standout
Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry
2003
Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression
2017 Standout
Resistant Hypertension Revisited: A Comparison of Two University-Based Cohorts
2005
Reactive Oxygen Species and the Central Nervous System
1992 Standout
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
2012
Bardoxolone methyl: drug development for diabetic kidney disease
2020
Risk factors for vertebral fractures in renal osteodystrophy
1999
12 Renal pathology in pre-eclampsia
1994
Effect of Gender on the Progression of Nondiabetic Renal Disease
2000
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
2010 Standout
Diuretic and Enhanced Sodium Restriction Results in Improved Antiproteinuric Response to RAS Blocking Agents
2004
Risk Factors for Hip Fracture in Hemodialysis Patients
2002
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
2016 Standout
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
2013
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
A comparison of quantitative computed tomography and dual x-ray absorptiometry for evaluation of bone mineral density in patients on chronic hemodialysis
2001
Proteinuria as a Surrogate Outcome in CKD: Report of a Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
2009
Chronic kidney disease
2011 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Risk factors for reduced bone density in haemodialysis patients
1999
Racial differences in bone mineral density and bone loss among end-stage renal disease patients
1999
Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on blood pressure and the kidney
2003
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
Urinary Tract Infection: Clinical Practice Guideline for the Diagnosis and Management of the Initial UTI in Febrile Infants and Children 2 to 24 Months
2011 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Bone mineral density in haemodialysis patients: A comparative study of dual‐energy X‐ray absorptiometry and quantitative ultrasound
2000
Treatment of Hypertension in Patients 80 Years of Age or Older
2008 Standout
The glycocalyx—linking albuminuria with renal and cardiovascular disease
2015
Pre-eclampsia
2010 Standout
Oxidative stress in chronic kidney disease
2018 Standout
Oxidative Stress in Cancer
2020 Standout
Combination Therapy With an Angiotensin Receptor Blocker and an ACE Inhibitor in Proteinuric Renal Disease: A Systematic Review of the Efficacy and Safety Data
2006
The Functional Role of the Renin–Angiotensin System in Pregnancy and Preeclampsia
2008
Osteoporosis and renal dysfunction in a general population exposed to cadmium in China
2004
Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure
1999
Osteoporosis in hemodialysis patients revisited by bone histomorphometry: A new insight into an old problem
2006
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
2003 Standout
Bone density and heel ultrasound testing do not identify patients with dialysis-dependent renal failure who have had fractures
2002
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
Single versus dual blockade of the renin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathy
2004
Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy
2003
Early Change in Proteinuria as a Surrogate End Point for Kidney Disease Progression: An Individual Patient Meta-analysis
2014
Osteoporosis after solid organ and bone marrow transplantation
2003
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Microneedles for drug and vaccine delivery
2012 Standout
Epidemiology of urinary tract infections: incidence, morbidity, and economic costs
2002 Standout
Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
2006 Standout
Increased risk of hip fracture among patients with end-stage renal disease
2000
Hyperactivation of Nrf2 in early tubular development induces nephrogenic diabetes insipidus
2017
Effects of short‐term alendronate on bone mineral density in haemodialysis patients
2005
Gestational Hypertension and Preeclampsia in Living Kidney Donors
2014
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
2015 Standout
Screening of newborn babies for familial ureteric reflux
1997
Osteoporosis in the elderly with chronic kidney disease
2006
Chronic Kidney Disease
2016 Standout
Reactive Oxygen Comes of Age: Mechanism-Based Therapy of Diabetic End-Organ Damage
2019
Characterization of novel small-molecule NRF2 activators: Structural and biochemical validation of stereospecific KEAP1 binding
2016
Pre-eclampsia
2015 Standout
Circulating Angiogenic Factors and the Risk of Preeclampsia
2004 Standout
Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis
2019
Nrf2 activation improves experimental rheumatoid arthritis
2023 StandoutNobel
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
2010 Standout
Pharmacology and Clinical Drug Candidates in Redox Medicine
2015
Nrf2, the Master Regulator of Anti-Oxidative Responses
2017
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
2015
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Falls in hemodialysis patients: Prospective study of incidence, risk factors, and complications
2005
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
2010 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
Benefits and Harms of Statin Therapy for Persons With Chronic Kidney Disease
2012
Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease
2008
Oxygen radical mechanisms of brain injury following ischemia and reperfusion
1991
Soil Contamination in China: Current Status and Mitigation Strategies
2014 Standout
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease
2011
Serum Concentrations of Cross-Linked N-Telopeptides of Type I Collagen: New Marker for Bone Resorption in Hemodialysis Patients
2005
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
Glomerular endotheliosis in normal pregnancy and pre‐eclampsia
2003
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
25-Hydroxyvitamin D Deficiency and Diabetes Predict Reduced BMD in Patients With Chronic Kidney Disease
2006
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Bone Mineral Density: Serum Markers of Bone Turnover and Their Relationships in Peritoneal Dialysis
2004
Natural product and natural product derived drugs in clinical trials
2014 Standout
Novel N rf2 activators from microbial transformation products inhibit blood–retinal barrier permeability in rabbits
2014
The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway
2020
Mineralized bone loss at different sites in dialysis patients
1998
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Prevention of pre‐eclampsia in high risk women with renal disease: A prospective randomized trial of heparin and dipyridamole
1995
Cutaneous delivery of prophylactic and therapeutic vaccines: historical perspective and future outlook
2008
The Renal Lesion of Preeclampsia Revisited
1991
Systemic Activation of NRF2 Alleviates Lethal Autoimmune Inflammation in Scurfy Mice
2017 StandoutNobel
Activation of NRF2 Signaling in HEK293 Cells by a First-in-Class Direct KEAP1-NRF2 Inhibitor
2015
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of David Packham being referenced
Morphometric analysis of pre-eclampsia in women biopsied in pregnancy and post-partum
1988
Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials
2011
Phase I clinical trial of a human idiotypic p53 vaccine in patients with advanced malignancy
2004
Relative Incidence of ESRD Versus Cardiovascular Mortality in Proteinuric Type 2 Diabetes and Nephropathy: Results From the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) Database
2011
Randomized controlled crossover study of the effect on proteinuria and blood pressure of adding an angiotensin II receptor antagonist to an angiotensin converting enzyme inhibitor in normotensive patients with chronic renal disease and proteinuria
2002
Renal biopsy: indications and complications in pregnancy
1987
Pyridorin in Type 2 Diabetic Nephropathy
2011
Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy
2007
Dual blockade of the renin-angiotensin system compared with a 50% increase in the dose of angiotensin-converting enzyme inhibitor: effects on proteinuria and blood pressure
2004
Prevalence and risk factors for osteopenia in dialysis patients
1996
Sodium Zirconium Cyclosilicate in Hyperkalemia
2014
Glomerulosclerosis and hyalinosis in rabbits
1992
Sulodexide Fails to Demonstrate Renoprotection in Overt Type 2 Diabetic Nephropathy
2011
Mechanisms Contributing to Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl
2014
The significance of focal and segmental hyalinosis and sclerosis (FSHS) and nephrotic range proteinuria in IgA nephropathy.
1996
Effect of Sodium Zirconium Cyclosilicate on Potassium Lowering for 28 Days Among Outpatients With Hyperkalemia
2014
Primary glomerulonephritis and pregnancy.
1989
Sulodexide for Kidney Protection in Type 2 Diabetes Patients With Microalbuminuria: A Randomized Controlled Trial
2011
Morphometric Analysis of Preeclampsia in Women Biopsied in Pregnancy and Post-Partum
1989
Effect of pravastatin on kidney function and urinary protein excretion in autosomal dominant polycystic kidney disease
2009
An assessment of the possible protective effect of allopurinol in acute stroke.
1986
Pregnancy-Related Complications in Women With Reflux Nephropathy
1994